The executive Director of the National Primary Healthcare Development Agency (NPHCDA) Dr Faisal Shuaib has announced that Nigeria is about to receive 3,930,910 doses of Pfizer-Bio-N Tech COVID-19 vaccine from the COVAX facility donated by the United States Government next month. An additional 3,577,860 doses of Pfizer-Bio-N Tech vaccine will also be received in the third quarter from the COVAX facility as well as 29,850,000 doses of Johnson & Johnson vaccine by the end of September courtesy of the African Union Commission.
These are separate from the 3,924,000 doses of Oxford/AstraZeneca expected to arrive by the end of July or early August also from the COVAX facility.
He made this known while briefing the press on the progress of Covid-19 vaccination in the country, as he said that the agency is putting in place all necessary logistics for storage, distribution, security, and accountability for the range of vaccines it is expecting. He also revealed that the Federal Government has procured 60 units of U701 ultra cold chain equipment, adding that about 37 of them have been deployed to all the 36 States and FCT in preparation to receive all COVID-19 vaccines that would require ultra-cold temperature of below 40 to 85 degrees.
He said in his statement that “It is with the support of our mainstream media community that Nigeria has successfully vaccinated 3,938,945 eligible persons across 36 States and FCT, representing 98% utilization of the 4,024,000 doses of Oxford/AstraZeneca vaccine it received from COVAX facility in March 2021. This comprises of 2,534,205 people who have been vaccinated for the first dose, and 1,404,205 who have received their second dose of the vaccine.”